Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Prostate Cancer Cells Express More Androgen Receptor (AR) Following Androgen Deprivation, Improving Recognition by AR-Specific T Cells.

Olson BM, Gamat M, Seliski J, Sawicki T, Jeffery J, Ellis L, Drake CG, Weichert J, McNeel DG.

Cancer Immunol Res. 2017 Dec;5(12):1074-1085. doi: 10.1158/2326-6066.CIR-16-0390. Epub 2017 Oct 19.

2.

Pretreatment antigen-specific immunity and regulation - association with subsequent immune response to anti-tumor DNA vaccination.

Johnson LE, Olson BM, McNeel DG.

J Immunother Cancer. 2017 Jul 18;5(1):56. doi: 10.1186/s40425-017-0260-3.

3.

Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate Immunity.

Patnaik A, Swanson KD, Csizmadia E, Solanki A, Landon-Brace N, Gehring MP, Helenius K, Olson BM, Pyzer AR, Wang LC, Elemento O, Novak J, Thornley TB, Asara JM, Montaser L, Timmons JJ, Morgan TM, Wang Y, Levantini E, Clohessy JG, Kelly K, Pandolfi PP, Rosenblatt JM, Avigan DE, Ye H, Karp JM, Signoretti S, Balk SP, Cantley LC.

Cancer Discov. 2017 Jul;7(7):750-765. doi: 10.1158/2159-8290.CD-16-0778. Epub 2017 Mar 8.

4.

Safety and Immunological Efficacy of a DNA Vaccine Encoding the Androgen Receptor Ligand-Binding Domain (AR-LBD).

Olson BM, Bradley ES, Sawicki T, Zhong W, Ranheim EA, Bloom JE, Colluru VT, Johnson LE, Rekoske BT, Eickhoff JC, McNeel DG.

Prostate. 2017 May;77(7):812-821. doi: 10.1002/pros.23321. Epub 2017 Feb 9.

5.

Antitumor vaccination of prostate cancer patients elicits PD-1/PD-L1 regulated antigen-specific immune responses.

Rekoske BT, Olson BM, McNeel DG.

Oncoimmunology. 2016 Mar 28;5(6):e1165377. doi: 10.1080/2162402X.2016.1165377. eCollection 2016 Jun.

6.

PD-1 or PD-L1 Blockade Restores Antitumor Efficacy Following SSX2 Epitope-Modified DNA Vaccine Immunization.

Rekoske BT, Smith HA, Olson BM, Maricque BB, McNeel DG.

Cancer Immunol Res. 2015 Aug;3(8):946-55. doi: 10.1158/2326-6066.CIR-14-0206. Epub 2015 Jun 3.

7.

Real-time immune monitoring to guide plasmid DNA vaccination schedule targeting prostatic acid phosphatase in patients with castration-resistant prostate cancer.

McNeel DG, Becker JT, Eickhoff JC, Johnson LE, Bradley E, Pohlkamp I, Staab MJ, Liu G, Wilding G, Olson BM.

Clin Cancer Res. 2014 Jul 15;20(14):3692-704. doi: 10.1158/1078-0432.CCR-14-0169. Epub 2014 May 21.

8.

Preclinical and clinical development of DNA vaccines for prostate cancer.

Colluru VT, Johnson LE, Olson BM, McNeel DG.

Urol Oncol. 2016 Apr;34(4):193-204. doi: 10.1016/j.urolonc.2013.09.014. Epub 2013 Dec 12. Review.

9.

Prostate carcinoma in transgenic Lewis rats - a tumor model for evaluation of immunological treatments.

Johnson LE, Becker JT, Dubovsky JA, Olson BM, McNeel DG.

Chin Clin Oncol. 2013 Mar 1;2(1). doi: 10.3978/j.issn.2304-3865.2012.11.06.

10.

Interleukin 35: a key mediator of suppression and the propagation of infectious tolerance.

Olson BM, Sullivan JA, Burlingham WJ.

Front Immunol. 2013 Oct 18;4:315. doi: 10.3389/fimmu.2013.00315. Review.

11.

Monitoring regulatory immune responses in tumor immunotherapy clinical trials.

Olson BM, McNeel DG.

Front Oncol. 2013 May 6;3:109. doi: 10.3389/fonc.2013.00109. eCollection 2013.

12.

Vaccination using peptides spanning the SYT-SSX tumor-specific translocation.

Bloom JE, McNeel DG, Olson BM.

Expert Rev Vaccines. 2012 Dec;11(12):1401-4. doi: 10.1586/erv.12.122.

13.

Antigen loss and tumor-mediated immunosuppression facilitate tumor recurrence.

Olson BM, McNeel DG.

Expert Rev Vaccines. 2012 Nov;11(11):1315-7. doi: 10.1586/erv.12.107.

14.

Human prostate tumor antigen-specific CD8+ regulatory T cells are inhibited by CTLA-4 or IL-35 blockade.

Olson BM, Jankowska-Gan E, Becker JT, Vignali DA, Burlingham WJ, McNeel DG.

J Immunol. 2012 Dec 15;189(12):5590-601. doi: 10.4049/jimmunol.1201744. Epub 2012 Nov 14.

15.

DNA Vaccines for Prostate Cancer.

McNeel DG, Becker JT, Johnson LE, Olson BM.

Curr Cancer Ther Rev. 2012 Nov 1;8(4):254-263.

16.

The androgen receptor: a biologically relevant vaccine target for the treatment of prostate cancer.

Olson BM, Johnson LE, McNeel DG.

Cancer Immunol Immunother. 2013 Mar;62(3):585-96. doi: 10.1007/s00262-012-1363-9. Epub 2012 Oct 30.

17.

Evaluation of cattle bedding and grazing BMPs in an agricultural watershed in Alberta.

Olson BM, Kalischuk AR, Casson JP, Phelan CA.

Water Sci Technol. 2011;64(2):326-33.

PMID:
22097003
18.

Phosphorus and nitrogen in runoff after phosphorus- or nitrogen-based manure applications.

Miller JJ, Chanasyk DS, Curtis TW, Olson BM.

J Environ Qual. 2011 May-Jun;40(3):949-58. doi: 10.2134/jeq2010.0279.

PMID:
21546681
19.

CD8+ T cells specific for the androgen receptor are common in patients with prostate cancer and are able to lyse prostate tumor cells.

Olson BM, McNeel DG.

Cancer Immunol Immunother. 2011 Jun;60(6):781-92. doi: 10.1007/s00262-011-0987-5. Epub 2011 Feb 25.

20.

Sipuleucel-T: immunotherapy for advanced prostate cancer.

Olson BM, McNeel DG.

Open Access J Urol. 2011 May 3;3:49-60. doi: 10.2147/OAJU.S13069. Review.

21.

DNA vaccine encoding prostatic acid phosphatase (PAP) elicits long-term T-cell responses in patients with recurrent prostate cancer.

Becker JT, Olson BM, Johnson LE, Davies JG, Dunphy EJ, McNeel DG.

J Immunother. 2010 Jul-Aug;33(6):639-47. doi: 10.1097/CJI.0b013e3181dda23e.

22.

HLA-A2-restricted T-cell epitopes specific for prostatic acid phosphatase.

Olson BM, Frye TP, Johnson LE, Fong L, Knutson KL, Disis ML, McNeel DG.

Cancer Immunol Immunother. 2010 Jun;59(6):943-53. doi: 10.1007/s00262-010-0820-6. Epub 2010 Feb 6.

23.

Nitrate leaching in two irrigated soils with different rates of cattle manure.

Olson BM, Bennett DR, McKenzie RH, Ormann TD, Atkins RP.

J Environ Qual. 2009 Oct 29;38(6):2218-28. doi: 10.2134/jeq2008.0519. Print 2009 Nov-Dec.

PMID:
19875777
24.

Methods for constructing and evaluating antitumor DNA vaccines.

Olson BM, McNeel DG.

Methods Mol Biol. 2009;542:211-43.

PMID:
19565905
25.

Development of computerized alerts with management strategies for 25 serious drug-drug interactions.

Murphy JE, Malone DC, Olson BM, Grizzle AJ, Armstrong EP, Skrepnek GH.

Am J Health Syst Pharm. 2009 Jan 1;66(1):38-44. doi: 10.2146/ajhp070046.

PMID:
19106343
26.

Physical and chemical properties of feedlot pen surfaces located on moderately coarse- and moderately fine-textured soils in southern Alberta.

Miller JJ, Curtis T, Larney FJ, McAllister TA, Olson BM.

J Environ Qual. 2008 Jun 23;37(4):1589-98. doi: 10.2134/jeq2007.0422. Print 2008 Jul-Aug.

PMID:
18574192
27.

Need for informed consent for dentists who use mercury amalgam restorative material as well as technical considerations in removal of dental amalgam restorations.

Edlich RF, Greene JA, Cochran AA, Kelley AR, Gubler KD, Olson BM, Hudson MA, Woode DR, Long WB 3rd, McGregor W, Yoder C, Hopkins DB, Saepoff JP.

J Environ Pathol Toxicol Oncol. 2007;26(4):305-22.

PMID:
18197828
28.
29.

Update on the National Vaccine Injury Compensation Program.

Edlich RF, Olson DM, Olson BM, Greene JA, Gubler KD, Winters KL, Kelley AR, Britt LD, Long WB 3rd.

J Emerg Med. 2007 Aug;33(2):199-211. Epub 2007 Jun 18. Review.

PMID:
17692778
30.

Relationships between soil and runoff phosphorus in small Alberta watersheds.

Little JL, Nolan SC, Casson JP, Olson BM.

J Environ Qual. 2007 Jul 17;36(5):1289-300. Print 2007 Sep-Oct.

PMID:
17636290
31.

An innovative advance to increase the use of the vaccine information statement.

Edlich RF, Olson DM, Olson BM, Greene JA, Gubler KD, Winters KL, Poe MJ, Britt LD, Long WB 3rd.

J Emerg Med. 2007 Jul;33(1):81-9. Epub 2007 May 30.

PMID:
17630084
32.

Degree of phosphorus saturation thresholds in manure-amended soils of alberta.

Casson JP, Bennett DR, Nolan SC, Olson BM, Ontkean GR.

J Environ Qual. 2006 Oct 27;35(6):2212-21. Print 2006 Nov-Dec.

PMID:
17071891
33.

Phosphorus and nitrogen in rainfall simulation runoff after fresh and composted beef cattle manure application.

Miller JJ, Olson EC, Chanasyk DS, Beasley BW, Larney FJ, Olson BM.

J Environ Qual. 2006 Jul 6;35(4):1279-90. Print 2006 Jul-Aug.

PMID:
16825447
34.

Predicting phosphorus availability from soil-applied composted and non-composted cattle feedlot manure.

Zvomuya F, Helgason BL, Larney FJ, Janzen HH, Akinremi OO, Olson BM.

J Environ Qual. 2006 Apr 26;35(3):928-37. Print 2006 May-Jun.

PMID:
16641331
35.

Bedding and within-pen location effects on feedlot pen runoff quality using a rainfall simulator.

Miller JJ, Olson EC, Chanasyk DS, Beasley BW, Yanke LJ, Larney FJ, McAllister TA, Olson BM, Selinger LB.

J Environ Qual. 2006 Feb 2;35(2):505-15. Print 2006 Mar-Apr.

PMID:
16455851
36.

Consumer understanding and satisfaction associated with a 3-tier prescription drug benefit.

Olson BM, Malone DC, Zachary WM, Coons SJ.

J Manag Care Pharm. 2005 Jul-Aug;11(6):480-92.

37.

Quantity and quality of runoff from a beef cattle feedlot in southern Alberta.

Miller JJ, Handerek BP, Beasley BW, Olson EC, Yanke LJ, Larney FJ, McAllister TA, Olson BM, Selinger LB, Chanasyk DS, Hasselback P.

J Environ Qual. 2004 May-Jun;33(3):1088-97.

PMID:
15224948
38.

Industry's perception of presenting pharmacoeconomic models to managed care organizations.

Olson BM, Armstrong EP, Grizzle AJ, Nichter MA.

J Manag Care Pharm. 2003 Mar-Apr;9(2):159-67.

39.

Bedding and seasonal effects on chemical and bacterial properties of feedlot cattle manure.

Miller JJ, Beasley BW, Yanke LJ, Larney FJ, McAllister TA, Olson BM, Selinger LB, Chanasyk DS, Hasselback P.

J Environ Qual. 2003 Sep-Oct;32(5):1887-94.

PMID:
14535334
40.

A cross-reactive polyol-responsive monoclonal antibody useful for isolation of core RNA polymerase from many bacterial species.

Bergendahl V, Thompson NE, Foley KM, Olson BM, Burgess RR.

Protein Expr Purif. 2003 Sep;31(1):155-60.

PMID:
12963353
41.
42.

Approaches to pharmacy benefit management and the impact of consumer cost sharing.

Olson BM.

Clin Ther. 2003 Jan;25(1):250-72. Review.

PMID:
12637125
43.

Patterns of antidepressant use among children and adolescents.

Shireman TI, Olson BM, Dewan NA.

Psychiatr Serv. 2002 Nov;53(11):1444-50.

PMID:
12407273
44.

SOME AMINO ACID SEQUENCES IN BOVINE-LIVER CATALASE.

SCHROEDER WA, SHELTON JR, SHELTON JB, OLSON BM.

Biochim Biophys Acta. 1964 Jul 8;89:47-65. No abstract available.

PMID:
14213012

Supplemental Content

Loading ...
Support Center